News Digging > Podcasts > Complement Therapeutics raises €72m to combat leading cause of blindness
Complement Therapeutics raises €72m to combat leading cause of blindness
Complement Therapeutics raises €72m to combat leading cause of blindness,A preclinical biotechnology company, spun out of The University of Manchester, has announced the completion of a €72 million finance deal to develop

Complement Therapeutics raises €72m to combat leading cause of blindness

A preclinical biotechnology company, spun out of The University of Manchester, has announced the completion of a €72 million finance deal to develop